Cargando…

CAPTCHA as a Visual Performance Metric in Active Macular Disease

PURPOSE: CAPTCHA (completely automated public turing test to tell computers and humans apart) was designed as a spam prevention test. In patients with visual impairment, completion of this task has been assumed to be difficult; but to date, no study has proven this to be true. As visual function is...

Descripción completa

Detalles Bibliográficos
Autores principales: Vangipuram, Gautam, Lee, Aaron Y., Rezaei, Kasra A., Olmos De Koo, Lisa C., Chee, Yewlin E., Chao, Jennifer R., Egan, Catherine, Lee, Cecilia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590550/
https://www.ncbi.nlm.nih.gov/pubmed/31281669
http://dx.doi.org/10.1155/2019/6710754
_version_ 1783429582855077888
author Vangipuram, Gautam
Lee, Aaron Y.
Rezaei, Kasra A.
Olmos De Koo, Lisa C.
Chee, Yewlin E.
Chao, Jennifer R.
Egan, Catherine
Lee, Cecilia S.
author_facet Vangipuram, Gautam
Lee, Aaron Y.
Rezaei, Kasra A.
Olmos De Koo, Lisa C.
Chee, Yewlin E.
Chao, Jennifer R.
Egan, Catherine
Lee, Cecilia S.
author_sort Vangipuram, Gautam
collection PubMed
description PURPOSE: CAPTCHA (completely automated public turing test to tell computers and humans apart) was designed as a spam prevention test. In patients with visual impairment, completion of this task has been assumed to be difficult; but to date, no study has proven this to be true. As visual function is not well measured by Snellen visual acuity (VA) alone, we theorized that CAPTCHA performance may provide additional information on macular disease-related visual dysfunction. METHODS: This was designed as a pilot study. Active disease was defined as the presence of either intraretinal fluid (IRF) or subretinal fluid (SRF) on spectral-domain optical coherence tomography. CAPTCHA performance was tested using 10 prompts. In addition, near and distance VA, contrast sensitivity, and reading speed were measured. Visual acuity matched pseudophakic patients were used as controls. Primary outcome measures were average edit distance and percent of correct responses. RESULTS: 70 patients were recruited: 33 with active macular disease and 37 control subjects. Contrast sensitivity was found to be significantly different in both the IRF (p < 0.01) and SRF groups (p < 0.01). No significant difference was found comparing the odds ratio of average edit distance of active disease (IRF, SRF) vs. control (OR 1.09 (0.62, 1.90), 1.10 (0.58, 2.05), p=0.77,  0.77) or percent correct responses of active disease vs. control (OR 0.98 (0.96, 1.01), 1.09 (0.58, 2.05), p=0.22, 0.51) in CAPTCHA testing. The goodness of fit using logistic regression analysis for the dependent variables of either IRF or SRF did not improve accounting for average edit distance (p=0.49,  p=0.27) or percent correct (p=0.89,  p=0.61). CONCLUSIONS: Distance VA and contrast sensitivity are positively correlated with the presence of IRF and SRF in active macular disease. CAPTCHA performance did not appear to be a significant predictor of either IRF or SRF in our pilot study.
format Online
Article
Text
id pubmed-6590550
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65905502019-07-07 CAPTCHA as a Visual Performance Metric in Active Macular Disease Vangipuram, Gautam Lee, Aaron Y. Rezaei, Kasra A. Olmos De Koo, Lisa C. Chee, Yewlin E. Chao, Jennifer R. Egan, Catherine Lee, Cecilia S. J Ophthalmol Research Article PURPOSE: CAPTCHA (completely automated public turing test to tell computers and humans apart) was designed as a spam prevention test. In patients with visual impairment, completion of this task has been assumed to be difficult; but to date, no study has proven this to be true. As visual function is not well measured by Snellen visual acuity (VA) alone, we theorized that CAPTCHA performance may provide additional information on macular disease-related visual dysfunction. METHODS: This was designed as a pilot study. Active disease was defined as the presence of either intraretinal fluid (IRF) or subretinal fluid (SRF) on spectral-domain optical coherence tomography. CAPTCHA performance was tested using 10 prompts. In addition, near and distance VA, contrast sensitivity, and reading speed were measured. Visual acuity matched pseudophakic patients were used as controls. Primary outcome measures were average edit distance and percent of correct responses. RESULTS: 70 patients were recruited: 33 with active macular disease and 37 control subjects. Contrast sensitivity was found to be significantly different in both the IRF (p < 0.01) and SRF groups (p < 0.01). No significant difference was found comparing the odds ratio of average edit distance of active disease (IRF, SRF) vs. control (OR 1.09 (0.62, 1.90), 1.10 (0.58, 2.05), p=0.77,  0.77) or percent correct responses of active disease vs. control (OR 0.98 (0.96, 1.01), 1.09 (0.58, 2.05), p=0.22, 0.51) in CAPTCHA testing. The goodness of fit using logistic regression analysis for the dependent variables of either IRF or SRF did not improve accounting for average edit distance (p=0.49,  p=0.27) or percent correct (p=0.89,  p=0.61). CONCLUSIONS: Distance VA and contrast sensitivity are positively correlated with the presence of IRF and SRF in active macular disease. CAPTCHA performance did not appear to be a significant predictor of either IRF or SRF in our pilot study. Hindawi 2019-06-09 /pmc/articles/PMC6590550/ /pubmed/31281669 http://dx.doi.org/10.1155/2019/6710754 Text en Copyright © 2019 Gautam Vangipuram et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Vangipuram, Gautam
Lee, Aaron Y.
Rezaei, Kasra A.
Olmos De Koo, Lisa C.
Chee, Yewlin E.
Chao, Jennifer R.
Egan, Catherine
Lee, Cecilia S.
CAPTCHA as a Visual Performance Metric in Active Macular Disease
title CAPTCHA as a Visual Performance Metric in Active Macular Disease
title_full CAPTCHA as a Visual Performance Metric in Active Macular Disease
title_fullStr CAPTCHA as a Visual Performance Metric in Active Macular Disease
title_full_unstemmed CAPTCHA as a Visual Performance Metric in Active Macular Disease
title_short CAPTCHA as a Visual Performance Metric in Active Macular Disease
title_sort captcha as a visual performance metric in active macular disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590550/
https://www.ncbi.nlm.nih.gov/pubmed/31281669
http://dx.doi.org/10.1155/2019/6710754
work_keys_str_mv AT vangipuramgautam captchaasavisualperformancemetricinactivemaculardisease
AT leeaarony captchaasavisualperformancemetricinactivemaculardisease
AT rezaeikasraa captchaasavisualperformancemetricinactivemaculardisease
AT olmosdekoolisac captchaasavisualperformancemetricinactivemaculardisease
AT cheeyewline captchaasavisualperformancemetricinactivemaculardisease
AT chaojenniferr captchaasavisualperformancemetricinactivemaculardisease
AT egancatherine captchaasavisualperformancemetricinactivemaculardisease
AT leececilias captchaasavisualperformancemetricinactivemaculardisease